newsfilter
← Latest News
ACCESS Newswire·

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

- Dermata announced a strategic pivot to develop and commercialize over-the-counter skin care treatments -- Dermata plans to launch its first OTC product, a once weekly acne kit with its Spongilla technology, in